Announcements
Call for papers · 21 October 2026
Call for papers: medical informatics, artificial intelligence and biomedical engineering
AI Med welcomes original research articles, reviews, methods papers, short communications and perspectives with a clear clinical or biomedical application in three areas:
- Medical informatics — clinical information systems, electronic health records, clinical decision support, health data standards and applied medical information technologies.
- Computer science and artificial intelligence — machine learning, deep learning, medical imaging, natural language processing, causal inference and reproducible computational methods for medical and biomedical problems.
- Biomedical engineering — biomedical devices, biosensors, wearable and intelligent medical systems, biomaterials, tissue engineering and engineering validation for healthcare.
Purely theoretical computer science, non-medical engineering and manuscripts without a substantive medical application are outside the journal scope. Please read the guide for authors before submitting.
Journal news · 21 October 2026
Article processing charge waived until 31 December 2028
The article processing charge for AI Med is waived until 31 December 2028. After that date the standard charge is USD 800 per accepted article. A full waiver remains available for corresponding authors based in low-income countries.
Full details are published in the article processing charge policy.
Journal news · 21 October 2026
AI Med Volume 2, Issue 1 (2026) is complete
Volume 2, Issue 1 of AI Med is complete. The issue contains two articles:
- Artificial Intelligence-Driven Antibody-Drug Conjugate Development for Chronic Neuropathic Pain: From Target Discovery to Clinical Translation (DOI 10.71423/aimed.20260606)
- Celastrol induces ferroptosis in multiple myeloma associated with suppression of the squalene synthase-mediated lipid defense axis (DOI 10.71423/aimed.20261006)
AI Med publishes continuously: accepted articles appear online as soon as they are copyedited and typeset, and are collected into the current issue. All articles are open access under CC BY 4.0.
Journal news · 20 July 2026
Withdrawal notice: AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment
The article “AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment” (DOI 10.71423/aimed.20250103) has been withdrawn at the request of the author(s).
The withdrawal notice remains a public record and is excluded from the journal’s publication and discovery indexes. The full notice is available in the withdrawal notice record.